SOAT1 and cancer: Studies have shown that cancer stem cells have been proposed to explain the development of cancer and resistance to treatment, and activation of the JAK/STAT signalling pathway, or induction of other signals that interact with the JAK/STAT pathway, can promote the production and acquisition of drug resistance by cancer stem cells (Shibue and Weinberg, 2017; Dongre and Weinberg, 2019).